Related Experiment Videos
Obstacles and advances in non-viral gene delivery
C P Lollo1, M G Banaszczyk, H C Chiou
1Immune Response Corporation, 5935 Darwin Court, Carisbad, CA 92008, USA. clollo@imnr.com
Current Opinion in Molecular Therapeutics
|March 16, 2001
Summary
This review highlights advances in non-viral gene delivery, detailing strategies to enhance in vivo efficiency by overcoming barriers like particle stabilization and nuclear entry for gene therapy applications.
Area of Science:
- Biomedical Engineering
- Molecular Biology
- Gene Therapy
Background:
- Non-viral gene delivery faces significant barriers to efficient in vivo application.
- Overcoming these hurdles is crucial for advancing gene therapy clinical potential.
Purpose of the Study:
- To review recent progress and novel strategies for improving in vivo non-viral gene delivery efficiency.
- To detail promising approaches for overcoming specific delivery barriers.
- To discuss limitations and the role of preclinical models.
Main Methods:
- Review of recent scientific literature on non-viral gene delivery.
- Detailed examination of strategies targeting particle stabilization, cellular uptake, and nuclear translocation.
- Analysis of the impact of new findings on understanding in vivo delivery limitations.
Main Results:
- Identification of promising strategies to enhance particle stabilization and targeting.
- Discussion of methods to improve cytoplasmic entry and nuclear access.
- Evaluation of current understanding of in vivo delivery limitations.
Conclusions:
- Significant progress has been made in non-viral gene delivery strategies.
- Addressing specific barriers like nuclear entry is key to improving in vivo efficiency.
- Preclinical models are essential for translating gene therapy research into clinical applications.